Shots: The company has reported the initiation of the first clinical trial of REGN-COV2. The REGN-COV2 clinical program will consist of four separate study populations: hospitalized COVID-19 patients, non-hospitalized symptomatic […]readmore
Tags : Antibody Cocktail
Shots: Regeneron reports that its investigational Ab cocktail for COVID-19 may be available for use by the end of summer as it ramps up the efforts to initiate the clinical […]readmore